CIK 0001621227
- Non-accelerated filer
- Smaller reporting company
Adaptimmune Therapeutics PLC
Sign in to watch- Ticker
- ADAPY
- Exchange
- OTC
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- United Kingdom
- Entity type
- Operating
- Phone
- +44 1235430000
- Business address
- 60 JUBILEE AVENUE, MILTON PARK, ABINGDON, OXFORDSHIRE, United Kingdom
- Former names
- Adaptimmune Ltd
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Open-market buy Director bought 47,280 shares at $0.84 ($39,715)
- 4 Open-market sale Chief Technology Officer sold 25,000 shares at $13.79 ($344,750)
- 4 Open-market buy 10% owner bought 15,000,000 shares at $1.67 ($25,000,500)
- 4 Open-market buy 10% owner bought 15,000,000 shares at $1.67 ($25,000,500)
- 4 Open-market buy 10% owner bought 15,000,000 shares at $1.67 ($25,000,500)
- 4 Open-market buy Director bought 15,000,000 shares at $1.67 ($25,000,500)
- 4 Open-market buy 10% owner bought 3,000,000 shares at $1.67 ($5,000,100)
- 4 Open-market buy 10% owner bought 15,000,000 shares at $1.67 ($25,000,500)
- 4 Open-market buy Director bought 12,000,000 shares at $1.67 ($20,000,400)
- 4 Open-market buy 10% owner bought 15,000,000 shares at $1.67 ($25,000,500)
- 4 Open-market buy 10% owner bought 15,000,000 shares at $1.67 ($25,000,500)
- 4 Open-market buy 10% owner bought 3,000,000 shares at $1.67 ($5,000,100)
- 4 Open-market buy 10% owner bought 3,000,000 shares at $1.67 ($5,000,100)
- 4 Open-market sale Chief Technology Officer sold 25,000 shares at $10.25 ($256,250)
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
Page 12 of 18 · 351 filings